» Articles » PMID: 24846478

Anti-inflammatory Strategies in Cartilage Repair

Overview
Date 2014 May 22
PMID 24846478
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Cartilage defects are normally concomitant with posttraumatic inflammation and pose a major challenge in cartilage repair. Due to the avascular nature of cartilage and its inability to surmount an inflammatory response, the cartilage is easily attacked by proinflammatory factors and oxidative stress; if left untreated, osteoarthritis may develop. Suppression of inflammation has always been a crux for cartilage repair. Pharmacological drugs have been successfully applied in cartilage repair; however, they cannot optimally work alone. This review article will summarize current pharmacological drugs and their application in cartilage repair. The development of extracellular matrix-based scaffolds and preconditioned tissue-specific stem cells will be emphasized because both of these tissue engineering components could contribute to an enhanced ability not only for cartilage regeneration but also for anti-inflammation. These strategies could be combined to boost cartilage repair under inflammatory conditions.

Citing Articles

Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CXCR1 synovial lining macrophage barrier.

Wang L, Hao M, Xu Y, Wang Z, Xie H, Zhang B Stem Cell Res Ther. 2025; 16(1):111.

PMID: 40038808 PMC: 11881422. DOI: 10.1186/s13287-025-04144-5.


Advances and Challenges in the Pursuit of Disease-Modifying Osteoarthritis Drugs: A Review of 2010-2024 Clinical Trials.

Brandt M, Malone J, Kean T Biomedicines. 2025; 13(2).

PMID: 40002768 PMC: 11853018. DOI: 10.3390/biomedicines13020355.


Decoding Cytokine Dynamics: Wharton's Jelly Stromal Cells and Chondro-Differentiates in PHA-Stimulated Co-Culture.

Meenakshi Sundaram R, Rupert S, Srinivasan P, Sathyanesan J, Govarthanan K, Jeyaraman N Cells. 2025; 14(3).

PMID: 39936966 PMC: 11817647. DOI: 10.3390/cells14030174.


Repetitive Overuse Injury Causes Entheseal Damage and Palmar Muscle Fibrosis in Older Rats.

Patel P, Tamas I, Van Der Bas M, Kegg A, Hilliard B, Lambi A Int J Mol Sci. 2025; 25(24).

PMID: 39769311 PMC: 11679654. DOI: 10.3390/ijms252413546.


Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.

Wu K, Chang Y, Ding D, Lin S Int J Mol Sci. 2024; 25(23.

PMID: 39684619 PMC: 11641625. DOI: 10.3390/ijms252312911.


References
1.
Ahmed S, Rahman A, Hasnain A, Goldberg V, Haqqi T . Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1. J Pharmacol Exp Ther. 2003; 305(3):981-8. DOI: 10.1124/jpet.102.048611. View

2.
Kunze R, Hempel U, Dieter P . Differential effect of chondroitin-4-sulfate on the immediate and delayed prostaglandin E2 release from osteoblasts. Prostaglandins Other Lipid Mediat. 2010; 92(1-4):8-12. DOI: 10.1016/j.prostaglandins.2010.01.001. View

3.
Kuma Y, Sabio G, Bain J, Shpiro N, Marquez R, Cuenda A . BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem. 2005; 280(20):19472-9. DOI: 10.1074/jbc.M414221200. View

4.
Kajahn J, Franz S, Rueckert E, Forstreuter I, Hintze V, Moeller S . Artificial extracellular matrices composed of collagen I and high sulfated hyaluronan modulate monocyte to macrophage differentiation under conditions of sterile inflammation. Biomatter. 2013; 2(4):226-36. PMC: 3568108. DOI: 10.4161/biom.22855. View

5.
Li J, He F, Pei M . Creation of an in vitro microenvironment to enhance human fetal synovium-derived stem cell chondrogenesis. Cell Tissue Res. 2011; 345(3):357-65. DOI: 10.1007/s00441-011-1212-8. View